Overview

Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)

Status:
Terminated
Trial end date:
2020-06-17
Target enrollment:
Participant gender:
Summary
Study of the long term safety of serlopitant for the treatment of pruritus in adults.
Phase:
Phase 3
Details
Lead Sponsor:
Menlo Therapeutics Inc.
Vyne Therapeutics Inc.
Treatments:
Serlopitant